ABVC BioPharma, Inc. (ABVC)
Develops experimental drugs for cancer, depression, ADHD, and eye diseases.
$1.05+0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-61.8%
The outlook
ABVC is trading near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage appears limited, and the overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Market cap
$27.3M
52-wk high
$3.40
52-wk low
$0.88
50-day avg
$1.35
200-day avg
$1.80
Trailing P/E
—